SCHEMBL4470605

SCHEMBL4470605

O=C(Nc1cc(Br)c(F)cc1F)c1ccccc1C(=O)c1ccc2n[c][nH]c2c1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NPC1 O15118 4/20 0.40
▸ RAB9A P51151 4/20 0.40
▸ HPGD P15428 1/20 0.39
▸ SMN1; SMN2 Q16637 1/20 0.39
▸ MAPT P10636 4/20 0.38
▸ CYP2C9 P11712 2/20 0.38
▸ CYP2C19 P33261 2/20 0.38
▸ KMT2A Q03164 2/20 0.38
▸ NPSR1 Q6W5P4 2/20 0.38
▸ KDM4E B2RXH2 1/20 0.38
▸ ALDH1A1 P00352 1/20 0.38
▸ CYP1A2 P05177 1/20 0.38
▸ CYP2D6 P10635 1/20 0.38
▸ MAPK1 P28482 1/20 0.38
▸ RAF1 P04049 2/20 0.37
▸ BRAF P15056 2/20 0.37
▸ PPARG P37231 1/20 0.37
▸ NR1H4 Q96RI1 1/20 0.37
▸ POLB P06746 2/20 0.36
▸ CASP6 P55212 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3850936 0.88 GPR35 (0.43) NPC1RAB9AHPGDSMN1; SMN2MAPT
SCHEMBL3848177 0.86 MAPT (0.44) NPC1RAB9AHPGDSMN1; SMN2MAPT
SCHEMBL3855951 0.84 NPSR1 (0.48) NPC1RAB9ASMN1; SMN2MAPTCYP2C9
SCHEMBL27774235 0.82 PPARG (0.39) MAPTCYP2C9CYP2C19KMT2ARAF1
SCHEMBL4473204 0.80 NPC1 (0.41) NPC1RAB9AHPGDMAPTCYP2C9
SCHEMBL2358832 0.80 RAF1 (0.54) NPC1RAB9AHPGDSMN1; SMN2MAPT
SCHEMBL3857514 0.79 RAF1 (0.38) NPC1RAB9AHPGDMAPTCYP2C9
SCHEMBL4469804 0.79 HTT (0.46) NPC1RAB9AHPGDSMN1; SMN2MAPT
SCHEMBL4464511 0.78 MAPT (0.44) NPC1RAB9AHPGDSMN1; SMN2MAPT
SCHEMBL3856725 0.78 RAF1 (0.37) NPC1RAB9AMAPTCYP2C9CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2009017838-A2 COMBINATIONS OF JAK-2 INHIBITORS AND OTHER AGENTS EXELIXIS, INC. (US) 2009-02-05 — — WO claimed
Send feedback